欧洲脱发治疗市场 – 行业趋势和 2030 年预测

 欧洲脱发治疗市场分析及规模

随着时间的流逝，由于不健康的饮食习惯和久坐的生活方式，脱发变得越来越普遍。此外，脱发还因衰老和荷尔蒙失衡以及癌症、高血压、关节炎和抑郁症等慢性疾病的增加而引起，主要发生在中年人群中。根据美国脱发协会的数据，雄激素性脱发导致男性脱发占男性脱发的近 95%。超过 80 万人正在寻找解决脱发的方法。

Data Bridge Market Research 分析了 2023-2030 年预测期内脱发治疗（脱发）市场的增长率。在上述预测期内，脱发治疗（脱发）市场的预期复合年增长率趋于 6.70% 左右。2022 年市场价值为 10.054 亿美元，到 2030 年将增长至 16.891 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

欧洲脱发治疗（脱发）市场范围和细分

市场定义

随着脱发问题的日益严重，全球对脱发治疗产品的需求也大幅增加。人们越来越意识到脱发​​治疗可以帮助避免脱发并恢复头发生长。脱发是一种由特定疾病或营养失调引起的脱发。久坐的生活方式和不健康的饮食习惯导致脱发越来越普遍。根据美国脱发协会的数据，雄激素性脱发约占男性脱发的 95%。

欧洲脱发治疗市场动态

驱动程序

• 脱发发生率不断上升

脱发的日益普遍预计将推动脱发治疗市场的增长。例如，大约一半的男性会秃顶，占 42.79%，在捷克共和国，秃顶非常普遍。此外，西班牙的男性脱发率排名第二，为 42.6%，其次是德国，男性脱发率为 41.2%，法国为 39.24%。此外，无论性别如何，近 2% 的人口在其一生中都面临着接受脱发治疗的高风险。卫生部门的进一步统计数据显示，欧洲城市居民的护发消费每年以 30% 的速度增长，预计未来几年将增加头发营养、修复和移植业务。然而，脱发问题最严重、最严重的 10 个国家中有 8 个是欧洲国家。因此，它促进了市场的增长。

机会

• 富血小板血浆疗法的广泛应用

预计富血小板血浆疗法的普及将为市场参与者带来巨大的增长机会。例如，意大利第二大学整形和重建外科的几位研究人员在 2020 年 4 月表示，与米诺地尔和非那雄胺相比，富血小板血浆被认为是治疗脱发的安全有效的替代品。因此，这促进了市场的增长。   

• 有机护发产品的使用率不断提高

Traditional natural and herbal based products are more incident for the treatment of hair loss problems in countries such as India and China. The organic hair loss products are most likely to be pushed by males, because they are more susceptible to hair losses. In general, the hair type among Asians is not quite as vulnerable to genetic thinning as western hair, but that affects a million men and women with hair loss. Thus, it increases the market growth.

Restraints/Challenges

• Limited Efficacy of Hair Loss Drugs

Limited efficacy and lack of evidence suggest that clinical efficacy of the existing hair loss drugs is hindering market growth. For instance, current topical hair loss treatments are widely available in the market such as minoxidil are not 100% effective for the treatment of alopecia, although it has been clinically proven to decrease the progression of hair loss.

• Lack of Reimbursement Policies

There is a lack of reimbursement for hair loss treatment services, which are expected to restrict the market growth. Both public and private payers do not reimburse majority of the laser treatment services. The cost of such services varies greatly and there cannot be any standardization.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, Clariant Natural Ingredients launched Prunizen, a new natural “feel good” active with the goal of treating stress-induced hair loss, enhancing the vitality of the hair and density, and confirming the well-being of the hair and scalp.
• In 2021, Procter & Gamble acquired a haircare and lifestyle brand, Ouai, founded by beauty influencer and celebrity hairstylist Jen Atkin.
• In 2021, TRESemmé  launched a new line of natural hair care products in the U.K. named Pro Pure. The range included three shampoo and conditioner pairs: Damage Recovery, Radiant Color, and Airlight Volume.

Europe Alopecia Treatment (Hair Loss) Market Scope

The alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

• Non‒Cicatricial Alopecia
• Traction Alopecia
• Ciatricial Alopecia
• Others

Treatment

• Localized Therapies
• Medical Devices
• Systemic Therapies
• Herbal Treatment

Gender

• Male
• Female

Form

• Topical
• Oral
• Parenteral

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Alopecia Treatment (Hair Loss) Regional Analysis/Insights

The alopecia treatment (hair loss) market is analyzed and market size insights and trends are provided by disease type, treatment, gender, form, end user and distribution channel as referenced above.

The major countries covered in the alopecia treatment (hair loss) market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is leading the market growth rate due to the increased awareness among the population about the huge benefits of natural and organic products and the wide effects of harmful chemicals in the existing ones. Besides that, the rise in the population stating the issue or problem of hair loss among them is also driving the market's growth.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Europe Alopecia Treatment (Hair Loss) Share Analysis

The alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to alopecia treatment (hair loss) market

Key players operating in the alopecia treatment (hair loss) market include:

• Johnson & Johnson Private Limited (U.S.)
• GSK plc (U.K.)
• Merck & Co., Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Cipla Inc. (U.S.)
• Endo International plc (Ireland)
• Zydus Group (India)
• Abbott (U.S.)
• Aurobindo Pharma (India)
• Dr. Reddy's Laboratories Ltd.（印度）
• Perrigo Company plc（爱尔兰）
• Curallux, LLC.（美国）
• DR. KURT WOLFF GMBH & CO. KG（德国）
• WOCKHARDT（印度）

SKU-57063